LNP-mRNA Vaccine Targeting C. psittaci MOMP: Preclinical Ins
2026-07-22
A recent preclinical study demonstrates that an LNP-encapsulated mRNA vaccine encoding the major outer membrane protein (MOMP) of Chlamydia psittaci elicits robust humoral and cellular immunity and reduces pulmonary pathogen burden in mice. This work underscores the promise of mRNA vaccine platforms for zoonotic respiratory pathogens and provides technical benchmarks for future vaccine development.
Dibutyryl-cAMP, sodium salt: Applied Workflows for cAMP Rese
2026-07-22
Dibutyryl-cAMP, sodium salt empowers researchers with a stable, cell-permeable cAMP analog for precise signaling pathway manipulation in neurobiology, inflammation, and disease modeling. This article delivers evidence-driven protocol guidance, troubleshooting strategies, and integrative insights to achieve robust, reproducible results across advanced assay systems.
WTAP-Mediated GLS Splicing Drives Ferroptosis Resistance in
2026-07-21
This study uncovers how WTAP phosphorylation under EGFR-AKT signaling alters glutaminase (GLS) splicing, enabling hepatocellular carcinoma (HCC) cells to evade ferroptosis. The mechanistic insights suggest targeting m6A-dependent splicing events as a therapeutic avenue for overcoming metabolic resistance in HCC.
Concanavalin A Inhibits Coronavirus Entry via Conserved N-Gl
2026-07-21
The referenced study demonstrates that concanavalin A (ConA), a plant lectin, effectively blocks coronavirus entry by targeting phylogenetically conserved N-linked glycans on the viral spike protein. These findings pinpoint stable glycan motifs as promising antiviral targets and inform the development of broad-spectrum coronavirus inhibitors.
Pulsed Field Ablation Remodels Cardiac Microenvironment in A
2026-07-20
This study provides a high-resolution analysis of how pulsed field ablation (PFA) selectively ablates arrhythmogenic myocardium while minimizing collateral tissue damage. Using single-nucleus RNA sequencing, the authors map cell-type specific responses and inflammation dynamics, offering new mechanistic insights into cardiac wound healing after PFA.
Foxp1 Overexpression Suppresses PTH-Induced Valvular Calcifi
2026-07-20
This study demonstrates that endothelial-specific overexpression of Foxp1 inhibits parathyroid hormone-driven endothelial-to-mesenchymal transition (EndMT) and attenuates valvular calcification in chronic kidney disease (CKD) by suppressing Notch pathway activation. The findings highlight Foxp1 as a regulatory node in CKD-related cardiovascular pathology, suggesting new avenues for mechanistic research and targeted intervention.
PX-478 2HCl: Applied Workflows for Hypoxia Signaling Researc
2026-07-19
PX-478 2HCl stands apart as a HIF-1α inhibitor, empowering cancer and hypoxia researchers with reproducible, evidence-based protocols. Explore practical guidance, troubleshooting, and comparative insights for radiosensitization, cell-based assays, and in vivo models.
Tubastatin A Mitigates Myocardial Injury Post-Resuscitation
2026-07-18
A new porcine study demonstrates that Tubastatin A, a selective HDAC6 inhibitor, attenuates post-resuscitation myocardial damage by suppressing GSDME-mediated pyroptosis and MLKL-mediated necroptosis. This work advances understanding of targeted epigenetic modulation in acute cardiac injury with translational potential for myocardial protection.
MLKL Polymerization Triggers Lysosomal Permeabilization in N
2026-07-17
This study elucidates how polymerization of MLKL at lysosomal membranes initiates lysosomal membrane permeabilization (LMP), releasing cathepsin B and driving necroptosis. These mechanistic insights clarify previously unresolved steps in regulated necrotic cell death and highlight new experimental targets for cell death research.
Penicillin G Sodium: Shaping Translational Research Integrit
2026-07-17
Explore how Penicillin G Sodium’s mechanistic clarity and strategic deployment empower translational researchers to achieve reproducible, contamination-free workflows. This article bridges foundational biology, protocol innovation, and competitive context, offering actionable insights for next-generation infection models and clinical translation.
2-Hydroxypropyl-β-cyclodextrin: Technical Use and Protocol G
2026-07-16
2-Hydroxypropyl-β-cyclodextrin addresses the persistent challenge of solubilizing poorly water-soluble, hydrophobic compounds—particularly those with aromatic or phenyl groups—in pharmaceutical and biochemical research. Its validated use is as a drug formulation excipient or for pharmaceutical solubility improvement through inclusion complex formation. Applications outside these workflows are not supported by current documentation.
Structural Insights and Affinity Tuning of CD38 CAR Binders
2026-07-16
This study provides a high-resolution structural and functional analysis of two CD38-targeting CAR binders, RP02 and 028, revealing distinct epitope engagement and allosteric inhibition mechanisms. These findings inform rational affinity tuning strategies, with direct implications for safer, more selective CAR-T therapies targeting hematologic malignancies.
Foretinib (GSK1363089): Precision in Tumor Growth and Motili
2026-07-15
Explore the advanced use of Foretinib (GSK1363089) in dissecting tumor growth inhibition and cell motility responses in cancer research. This article offers a practical, evidence-driven guide for optimizing experimental design, grounded in the latest systems biology insights.
AZ505 and the Strategic Frontier of SMYD2 Inhibition in Tran
2026-07-15
AZ505, a potent and selective SMYD2 inhibitor from APExBIO, is redefining the landscape of translational epigenetic research. By uniquely targeting the substrate groove of SMYD2, AZ505 enables precise modulation of histone and non-histone methylation—offering new mechanistic insights and workflow advantages in cancer, fibrosis, and kidney disease models. This article synthesizes the latest evidence, translational protocols, and competitive perspectives to guide researchers seeking to exploit SMYD2 inhibition for both fundamental discovery and therapeutic innovation.
0.4% Trypan Blue Solution: Practical Guidance for Cell Viabi
2026-07-14
0.4% Trypan Blue Solution is a standard azo dye for cell staining, enabling direct discrimination between viable and non-viable cells during cell viability measurement and counting. It is designed for research use in cell culture and cytotoxicity workflows but is not intended for diagnostic or clinical applications. Proper handling and adherence to workflow best practices are essential to ensure reliable results.
459 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page